Progress of immunotherapy in the treatment of malignant melanoma.
作者信息
Ariyan S
出版信息
Yale J Biol Med. 1975 Nov;48(5):423-9.
Abstract
摘要
相似文献
1
Progress of immunotherapy in the treatment of malignant melanoma.
Yale J Biol Med. 1975 Nov;48(5):423-9.
2
[Immunology of melanoma].
Acta Chir Belg. 1974 Mar;73(2):135-88.
3
[Development in the immunotherapy of malignant melanoma].
Hautarzt. 1976 Jan;27(1):1-7.
4
Immunological studies on malignant melanomas of man.
Yale J Biol Med. 1973 Dec;46(5):693-701.
5
[Immunological aspects of melanoma].
Lakartidningen. 1976 Feb 11;73(7):528-30.
6
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Natl Cancer Inst Monogr. 1973 Dec;39:221-4.
7
Immune response and non-specific immunotherapy in melanoma.
Ann R Coll Surg Engl. 1978 Mar;60(2):117-20.
8
Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
Plast Reconstr Surg. 1975 Mar;55(3):294-8.
9
[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Vopr Onkol. 1977;23(8):27-33.
10
Immunotherapy and immune competence of patients with malignant melanoma.
Czech Med. 1983;6(3):172-4.
引用本文的文献
1
Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.
Cancer Immunol Immunother. 1986;22(3):197-203. doi: 10.1007/BF00200033.
本文引用的文献
1
Role of nonimmunized macrophages in the rejection of an allotransplanted lymphoma.
J Natl Cancer Inst. 1970 Mar;44(3):739-49.
2
Immunological factors which influence response to immunotherapy in malignant melanoma.
Surgery. 1970 Jul;68(1):158-63; discussion 163-4.
3
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5. doi: 10.1073/pnas.68.6.1372.
4
Clinical experiences in immunotherapy of cancer.
Surg Gynecol Obstet. 1971 Aug;133(2):209-17.
5
Tumors of the skin. X. Immunotherapy of cutaneous and mucosal neoplasms.
N Y State J Med. 1968 Apr 1;68(7):900-11.
6
Immunological effects of BCG in malignant melanoma: two modes of administration compared.
Ann Intern Med. 1972 Mar;76(3):405-11. doi: 10.7326/0003-4819-76-3-405.
7
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
Science. 1971 Nov 5;174(4009):591-3. doi: 10.1126/science.174.4009.591.
8
Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages.
J Natl Cancer Inst. 1973 Oct;51(4):1145-8. doi: 10.1093/jnci/51.4.1145.
9
BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Ann Surg. 1974 Oct;180(4):635-43. doi: 10.1097/00000658-197410000-00029.
10
The limited role of attenuated smallpox virus in the management of advanced malignant melanoma.
Aust N Z J Surg. 1966 May;35(4):286-90. doi: 10.1111/j.1445-2197.1966.tb03889.x.
Zotero 插件